Over-the-counter drug · OTC MONOGRAPH DRUG
Stool Softener Laxative Plus Stimulant (Docusate sodium and sennosides) NDC 55910-855
Docusate sodium 50 mg/1; Sennosides 8.6 mg/1 · Tablet · Oral · Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55910-855-10 | 5591008551055910085510 | 100 TABLET in 1 BOTTLE (55910-855-10)Marketed from Jun 30, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Stool Softener Laxative Plus StimulantSuffix: Plus Stimulant
- Generic name (nonproprietary)
- docusate sodium and sennosides
- Active ingredients
- Docusate sodium — 50 mg/1Sennosides — 8.6 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)NDC labeler code 55910
- Product type
- Over-the-counter drug
- Marketing category
- OTC monograph drugApplication 505G(a)(3)
- Marketing start
- Listing expires
- Identifiers
- Product ID 55910-855_65964980-2c06-4fd6-9e7a-a23b747fc038SPL ID 65964980-2c06-4fd6-9e7a-a23b747fc038SPL set ID 5bdc4291-2565-49be-93f1-84f60f983135RxCUI 998740UNII F05Q2T2JA0, 3FYP5M0IJXUPC 0359726286046
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N455910085510followed by a unit qualifier and the quantityPackage 55910-0855-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses relieves occasional constipation (irregularity) generally produces bowel movement in 6 to12 hours
Excerpt only. Read the full label for complete information.
About NDC 55910-855
- What is NDC 55910-855?
- 55910-855 is the product NDC for Stool Softener Laxative Plus Stimulant, Docusate sodium 50 mg/1; Sennosides 8.6 mg/1 tablet, listed with the FDA by Dolgencorp, Inc. (DOLLAR GENERAL & REXALL). It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Stool Softener Laxative Plus Stimulant (Docusate sodium and sennosides).
- What is the active ingredient?
- Docusate sodium, Sennosides.
- Who is the labeler?
- Dolgencorp, Inc. (DOLLAR GENERAL & REXALL), NDC labeler code 55910. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Stool Softener Laxative Plus Stimulant?
- 3 other product NDCs are listed under this name. See all Stool Softener Laxative Plus Stimulant NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Stool Softener Laxative Plus Stimulant products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Stool Softener Laxative Plus Stimulantdocusate sodium and sennosides | Docusate sodium 50 mg/1; Sennosides 8.6 mg/1 | TabletOral | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 55910-978 | 55910-0978-10 |
| Stool Softener Laxative Plus Stimulantdocusate sodium and sennosides | Docusate sodium 50 mg/1; Sennosides 8.6 mg/1 | TabletOral | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 55910-829 | 55910-0829-10 |
| Stool Softener Laxative Plus Stimulantdocusate sodium and sennosides | Docusate sodium 50 mg/1; Sennosides 8.6 mg/1 | TabletOral | Walgreens | 0363-0827 | 00363-0827-2000363-0827-60 |
Other NDCs under 505G(a)(3)
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
Showing 20 of 40.